Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, Drake CG, de Bono JS (2016) Prostate cancer. Lancet 387(10013):70–82
Howard N, Clementino M, Kim D, Wang L, Verma A, Shi X, Zhang Z, DiPaola RS (2019) New developments in mechanisms of prostate cancer progression. Semin Cancer Biol 57:111–116
Litwin MS, Tan HJ (2017) The diagnosis and treatment of prostate cancer: a review. JAMA 317(24):2532–2542
Ghosh S, Tvsvgk T, Somasundaram V, Deepti MJSJ (2021) The domino effect-treatment of superior vena cava obstruction triggering tumor lysis syndrome: a case report. SciMed J 3(1):44–50
Han B, Chao J, Yao H (2018) Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther 187:31–44
Li J, Sun D, Pu W, Wang J, Peng Y (2020) Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer 6(4):319–336
Taheri M, Najafi S, Basiri A, Hussen BM, Baniahmad A, Jamali E, Ghafouri-Fard S (2021) The role and clinical potentials of circular RNAs in prostate cancer. Front Oncol 11:781414
Zhang Y, Liu F, Feng Y, Xu X, Wang Y, Zhu S, Dong J, Zhao S, Xu B, Feng N (2022) CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9. Cancer Gene Ther. https://doi.org/10.1038/s41417-022-00492-z
Wang S, Chao F, Zhang C, Han D, Xu G, Chen G (2022) Circular RNA circPFKP promotes cell proliferation by activating IMPDH2 in prostate cancer. Cancer Lett 524:109–120
Zhang G, Liu Y, Yang J, Wang H, Xing Z (2021) Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via miR-1/MAP3K1 axis. J Gene Med. https://doi.org/10.1002/jgm.3376
Cozar JM, Robles-Fernandez I, Rodriguez-Martinez A, Puche-Sanz I, Vazquez-Alonso F, Lorente JA, Martinez-Gonzalez LJ, Alvarez-Cubero MJ (2019) The role of miRNAs as biomarkers in prostate cancer. Mutat Res 781:165–174
Khorasgani MA, Nejad PM, Bashi MMM, Hedayati MJSJ (2019) Increased expression of miR-377–3p in patients with relapsing remitting multiple sclerosis. SciMed J 1(2):48–54
Fabris L, Ceder Y, Chinnaiyan AM, Jenster GW, Sorensen KD, Tomlins S, Visakorpi T, Calin GA (2016) The potential of MicroRNAs as prostate cancer biomarkers. Eur Urol 70(2):312–322
Ru P, Steele R, Newhall P, Phillips NJ, Toth K, Ray RB (2012) miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol Cancer Ther 11(5):1166–1173
Jin M, Zhang T, Liu C, Badeaux MA, Liu B, Liu R, Jeter C, Chen X, Vlassov AV, Tang DG (2014) miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 74(15):4183–4195
Chao F, Song Z, Wang S, Ma Z, Zhuo Z, Meng T, Xu G, Chen G (2021) Novel circular RNA circSOBP governs amoeboid migration through the regulation of the miR-141-3p/MYPT1/p-MLC2 axis in prostate cancer. Clin Transl Med 11(3):e360
Chen Y, Yang F, Fang E, Xiao W, Mei H, Li H, Li D, Song H, Wang J, Hong M et al (2019) Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes. Cell Death Differ 26(7):1346–1364
Mao Y, Li W, Hua B, Gu X, Pan W, Chen Q, Xu B, Lu C, Wang Z (2020) Circular RNA_PDHX promotes the proliferation and invasion of prostate cancer by sponging MiR-378a-3p. Front Cell Dev Biol 8:602707
Chen W, Cen S, Zhou X, Yang T, Wu K, Zou L, Luo J, Li C, Lv D, Mao X (2020) Circular RNA CircNOLC1, upregulated by NF-KappaB, promotes the progression of prostate cancer via miR-647/PAQR4 axis. Front Cell Dev Biol 8:624764
Deng W, Zhou X, Zhu K, Chen R, Liu X, Chen L, Jiang H, Hu B, Zeng Z, Cheng X et al (2022) Novel circular RNA circ_0086722 drives tumor progression by regulating the miR-339-5p/STAT5A axis in prostate cancer. Cancer Lett 533:215606
Yang Z, Qu CB, Zhang Y, Zhang WF, Wang DD, Gao CC, Ma L, Chen JS, Liu KL, Zheng B et al (2019) Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene 38(14):2516–2532
Wu G, Sun Y, Xiang Z, Wang K, Liu B, Xiao G, Niu Y, Wu D, Chang C (2019) Preclinical study using circular RNA 17 and micro RNA 181c–5p to suppress the enzalutamide-resistant prostate cancer progression. Cell Death Dis 10(2):37
Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L (2019) MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. Int J Biol Macromol 129:227–232
Zhang Y, Shi Z, Li Z, Wang X, Zheng P, Li H (2020) Circ_0057553/miR-515-5p regulates prostate cancer cell proliferation, apoptosis, migration, invasion and aerobic glycolysis by targeting YES1. Onco Targets Ther 13:11289–11299
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S, Zhang M, Yu F, Peng Z, Zhou C (2016) Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer Res 35:15
Zhang Y, Pan Q, Shao Z (2020) Tumor-suppressive role of microRNA-202-3p in hepatocellular carcinoma through the KDM3A/HOXA1/MEIS3 pathway. Front Cell Dev Biol 8:556004
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
Kristensen LS, Hansen TB, Venø MT, Kjems J (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37(5):555–565
Greene J, Baird AM, Lim M, Flynn J, McNevin C, Brady L, Sheils O, Gray SG, McDermott R, Finn SP (2021) Differential CircRNA expression signatures may serve as potential novel biomarkers in prostate cancer. Front Cell Dev Biol 9:605686
Ganapathy-Kanniappan S, Geschwind JF (2013) Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 12:152
Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25(34):4633–4646
Khan S, Jha A, Panda AC, Dixit A (2021) Cancer-associated circRNA-miRNA-mRNA regulatory networks: a meta-analysis. Front Mol Biosci 8:671309
Pu Z, Xu M, Yuan X, Xie H, Zhao J (2020) Circular RNA circCUL3 accelerates the warburg effect progression of gastric cancer through regulating the STAT3/HK2 Axis. Mol Ther Nucleic Acids 22:310–318
Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang X, Xu S, Pang D (2019) LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res CR 38(1):418
Wang G, Zhao H, Duan X, Ren Z (2021) CircRNA pappalysin 1 facilitates prostate cancer development through miR-515-5p/FKBP1A axis. Andrologia 53(11):e14227
Liu GX, Zheng T, Zhang Y, Hao P (2022) CircFOXM1 silencing represses cell proliferation, migration and invasion by regulating miR-515-5p/ADAM10 axis in prostate cancer. Anticancer Drugs 33(1):e573–e583
Tischfield MA, Bosley TM, Salih MA, Alorainy IA, Sener EC, Nester MJ, Oystreck DT, Chan WM, Andrews C, Erickson RP et al (2005) Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development. Nat Genet 37(10):1035–1037
Li Q, Dong C, Cui J, Wang Y, Hong X (2018) Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. J Exp Clin Cancer Res CR 37(1):265
Wardwell-Ozgo J, Dogruluk T, Gifford A, Zhang Y, Heffernan TP, van Doorn R, Creighton CJ, Chin L, Scott KL (2014) HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene 33(8):1017–1026
Wang H, Liu G, Shen D, Ye H, Huang J, Jiao L, Sun Y (2015) HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells. Oncol Rep 34(3):1203–1210
Feng C, Wang Q, Deng L, Peng N, Yang M, Wang X (2022) Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy. Andrologia 54(1):e14312
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.springeropen.com/)
